These symptoms are usually most noticeable in the first weeks of treatment or after a dose increase
95% CI [0.800.96]), cardiovascular mortality (HR 0.88
The most frequently reported side effects of semaglutide include nausea, vomiting, diarrhoea, constipation, and abdominal discomfort symptoms that often discourage adequate nutritional intake and may affect overall nutritional status if not properly managed
Our approach emphasizes holistic care, ensuring that each patient receives comprehensive support that addresses their physical, mental, and emotional well-being
The standard dosing schedule begins at 0.25 mg once weekly for four weeks (initiation dose to improve gastrointestinal tolerability), then increases to 0.5 mg once weekly
Multiple studies confirm its effectiveness against GI distress